Molecular
-
Molecular Profiles invests in new facility to increase manufacturing capabilities for clinical trials
Molecular Profiles, a leading specialist contract research and manufacturing organization, announces the commencement of construction of a new manufacturing facility. This £9 million investment will allow Molecular Profiles to expand its current manufacturing capabilities while strengthening its existing expertise in the drug development field.
Molecular | 19 January 2012
-
Abbott submits molecular test for lung cancer therapy
Abbott announced it filed premarket approval applications to the US FDA and the Japanese Ministry of Health, Labour, and Welfare for a new molecular diagnostic test designed to detect abnormal gene rearrangements in non-small-cell lung cancer (NSCLC)…
Molecular | 23 May 2011
-
Allergan and Molecular Partners enter into license agreement for MP0112
Allergan Inc and Molecular Partners AG announced that they have entered into a license agreement for MP0112, a phase 2 proprietary therapeutic DARPin protein targeting VEGF under investigation for the treatment of retinal diseases. Under the agre…
Molecular | 05 May 2011
-
Standardized solutions for molecular analysis of FFPE samples
Qiagen has launched several products that assist in the molecular analysis of formalin-fixed, paraffin-embedded (FFPE) tissue samples. The offering provides scientists with a range of dedicated kits over the whole FFPE workflow, from the isolati…
Molecular | 21 November 2010
-
US FDA approves first automated molecular test for assessing hepatitis B treatment
Abbott receives approval from US FDA to market the RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sa…
Molecular | 23 September 2010
-
Automated system for molecular testing
Qiagen launches the flexible automated solution QIAsymphony RGQ. This novel, integrated system is for molecular testing and incorporates all workflow steps from sample to detection. QIAsymphony offers many features which create flexibility, such…
Molecular | 20 September 2010
-
Amsterdam Molecular Therapeutics Reports Promising Data
Amsterdam Molecular Therapeutics (AMT) reports positive preclinical data from a study using an AAV gene therapy product to lower cholesterol. The data show that a single dose of the gene therapy carrying a short hairpin RNA to silence Apolipoprotein…
Molecular | 04 June 2010
-
NAG: More GPU Routines for Drug Discovery Research
Pharmaceutical developers involved in Deoxyribonucleic Acid (DNA) sequencing and dynamic molecular modeling for drug discovery who are interested in achieving performance from Graphical Processing Units (GPUs) in diverse applications using Monte Carl…
Molecular | 20 May 2010
-
GIS Scientists Gain Understanding on Mammalian Development
Scientists at the Genome Institute of Singapore (GIS) have generated significant single cell expression data crucial for a detailed molecular understanding of mammalian development from fertilization to embryo implantation – a process known as the …
Molecular | 19 May 2010
-
Carestream Molecular Imaging Signs Agreement with OncoVision
Carestream Molecular Imaging has signed an exclusive, multi-year agreement with OncoVision (Valencia, Spain), to sell, market and service the Albira PET/SPECT/CT imaging system for small animal research. With the addition of this multimodal imaging s…
Molecular | 28 April 2010
